←
PanACEA233 posts
PanACEA avatar

PanACEA

@PanACEA_II

A drug development programme to shorten and simplify treatment of tuberculosis.

◷ Joined March 2017▧ 38 Photos and videos
PanACEA avatar
PanACEA@PanACEA_II·5 Jun 2025

Day 3 — the final day of the SimpliciTB & PanACEA II close-out meeting. Today we’re not just wrapping up, we’re planning forward: shaping the future of TB research, collaboration & innovation. Grateful for the journey, excited for what’s ahead. @edctp @tballiance #endTB

Post attachmentPost attachmentPost attachment
PanACEA avatar
PanACEA@PanACEA_II·4 Jun 2025

Kicking off Day 2 of the SimpliciTB & Panacea II close out Meeting in Cape Town! Yesterday reminded us how far we’ve come — from milestones in clinical progress to growing global partnerships. Onward together in the fight against #TB. @EDCTP @TBAlliance #PanaceaII #EndTB

Post attachmentPost attachment
PanACEA avatar
PanACEA@PanACEA_II·15 Nov 2023

Looking back at another great edition of the EDCTP forum! We were very happy to see so many of our PanACEA members attending and contributing to the insightful sessions. And we were proud to see some of the amazing PanACEA work presented! @EDCTP @KCRITanzania @TBtrials_StAnd

Post attachmentPost attachmentPost attachment
PanACEA avatar
PanACEA@PanACEA_II·2 Mar 2023

We successfully completed our first site initiation visit for the STEP2C study at TASK in South Africa. We are so excited to start enrolling our first patient soon! @PanACEA_II @EDCTP

Post attachment
PanACEA avatar
PanACEA@PanACEA_II·21 Feb 2023

Today Norbert Heinrich presented the PanACEA SUDOCU study results at @CROI_Official in Seattle: sutezolid on top of a background regimen (bedaquiline, delamanid, moxifloxacin) was well tolerated when given over 12 weeks and improved the treatment efficacy modestly. TNX to @EDCTP

Post attachmentPost attachment
NIMR Mbeya avatar
⟳ PanACEA retweeted
NIMR Mbeya@NIMRMbeya·19 Sep 2022

Our Centre Director @NNtinginya presenting on the clinical utility of the Molecular Bacterial Load Assay (MBLA) in monitoring TB therapy through the @EDCTP funded SimpliciTB-PanACEA network at Kamuzu University of Health Sciences, Malawi @KUHeS_mw @PanACEA_II

Post attachmentPost attachment